SMS Pharmaceuticals Limited has informed the Exchange that Record date for the purpose of Dividend is 22-Sep-2025.
SMSPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
SMS Pharmaceuticals' Board met on August 9, 2025 and approved standalone and consolidated unaudited financial results for Q1 FY26 (quarter ended June 30, 2025). Standalone revenue from operations rose to Rs. 19,604.71 lakhs, up about 19% from Rs. 16,445.13 lakhs in Q1 FY25, while standalone net profit stood at Rs. 1,820.75 lakhs (vs Rs. 1,632.83 lakhs, ~11.5% growth). Consolidated net profit after share of associate was Rs. 2,049.05 lakhs (~24% YoY) with EPS of Rs. 2.31. The 37th AGM is scheduled for September 29, 2025 via video conference, the Register of Members will be closed from September 23–29, 2025, and the record date for the FY25 dividend (subject to AGM approval) has been fixed at September 22, 2025. The statutory auditor issued an un-modified limited review report on both results.
Healthy topline growth, steady profitability, and a proposed dividend are positive signals for shareholders. The record date of September 22, 2025 is the key date for investors to be eligible for the FY25 dividend, once approved at the AGM.